Morgan Stanley Inst Inception I holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Morgan Stanley Institutional Fund, Inc. Inception Portfolio Class I MSSGX
- NAV / 1-Day Return 17.34 / −0.29 %
- Total Assets 221.9M
-
Adj. Expense Ratio
1.000%
- Expense Ratio 1.000%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Blend
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 97%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MSSGX
Will MSSGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 55.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Agilon Health Inc | 9.08 | 26M | Healthcare |
Cloudflare Inc | 8.93 | 25M | Technology |
Opendoor Technologies Inc Ordinary Shares - Class A | 7.37 | 21M | Real Estate |
Aurora Innovation Inc Class A | 6.56 | 19M | Consumer Cyclical |
IonQ Inc | 5.86 | 17M | Technology |
X4 Pharmaceuticals Inc | 3.81 | 11M | Healthcare |
HealthEquity Inc | 3.60 | 10M | Healthcare |
Celsius Holdings Inc | 3.53 | 10M | Consumer Defensive |
Immunovant Inc | 3.43 | 10M | Healthcare |
GRAIL Inc | 3.19 | 9M | Healthcare |